TOP TEN perturbations for ZNF414 (Homo sapiens)
Organism: Homo sapiens
Gene: ZNF414
Selected probe(set): 227071_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of ZNF414 (227071_at) across 6540 perturbations tested by GENEVESTIGATOR:
stem cell differentiation study 41 (hES-T3 EB) / undifferentiated hES-T3 cell sample
Relative Expression (log2-ratio):-1.252634Number of Samples:2 / 3
Experimental | stem cell differentiation study 41 (hES-T3 EB) |
Sample of embryonic bodies (EB) differentiated from human embryonic stem cells T3 with female karyotype. | |
Control | undifferentiated hES-T3 cell sample |
Undifferentiated human embryonic stem cells T3. |
brefeldin A study 1 (0.5ug/ml; p53HCT116) / untreated p53HCT116 cell sample
Relative Expression (log2-ratio):-1.1867647Number of Samples:2 / 3
Experimental | brefeldin A study 1 (0.5ug/ml; p53HCT116) |
Derived human colon carcinoma cell line p53HCT116 with knockout gene for p53 was treated with 0.5 ug/ml brefeldin-A for 24 hours in McCOYs 5A medium supplemented with 10% heat inactivated FBS. ATC code:--- | |
Control | untreated p53HCT116 cell sample |
Derived human colon carcinoma cell line p53HCT116 with knockout gene for p53 was grown in McCOYs 5A medium supplemented with 10% heat inactivated FBS. |
Langerhans cell histiocytosis study 3 / normal tonsillar T-lymphocyte sample
Relative Expression (log2-ratio):1.0665016Number of Samples:10 / 4
Experimental | Langerhans cell histiocytosis study 3 |
CD3+ T-lymphocyte samples isolated from Langerhans cell histiocytosis (LCH) lesions in bone (8 cases) or skin (2 cases). Patient with different clinical status were included in this study (unifocal, single system; multifocal, single system and multifocal, multisystem disease). | |
Control | normal tonsillar T-lymphocyte sample |
Normal tonsillar CD3+ T-lymphocytes were isolated from children who undergone elective tonsillectomy. The T-cells were isolated from presumably healthy tissue. |
glioma study 16 (LN-215) / normal astrocyte sample
Relative Expression (log2-ratio):1.0227256Number of Samples:2 / 3
Experimental | glioma study 16 (LN-215) |
Human glioma cell line LN215 was cultured in DMEM supplemented with 10% FCS (fetal calf serum) and antibiotics at 37°C and 5% CO2. | |
Control | normal astrocyte sample |
Normal brain astrocytes. Clonetics normal human astrocytes (NHA) from Cambrex (primary-derived cultures) and cultured according to the manufacturer's recommendations. |
tunicamycin study 2 (2ug/ml; HCT 116) / untreated HCT 116 cell sample
Relative Expression (log2-ratio):-0.90876675Number of Samples:3 / 3
Experimental | tunicamycin study 2 (2ug/ml; HCT 116) |
Human colon carcinoma cell line HCT116 was treated with 2 ug/ml tunicamycin for 24 hours in McCOYs 5A medium supplemented with 10% heat inactivated FBS. ATC code:--- | |
Control | untreated HCT 116 cell sample |
Human colon carcinoma cell line HCT116 was grown in McCOYs 5A medium supplemented with 10% heat inactivated FBS. |
basal cell carcinoma study 3 / normal epidermal keratinocytes
Relative Expression (log2-ratio):-0.90349865Number of Samples:4 / 2
Experimental | basal cell carcinoma study 3 |
Primary tumor tissue from the eyelid of patients with basal cell carcinoma (BCC). | |
Control | normal epidermal keratinocytes |
Normal human epidermal keratinocytes (NHEK) (Kurabo Ind., Ltd., Osaka, Japan) cultured in HuMedia-KB2 medium at 37°C in humidified air containing 5% CO2. |
4-nitro-o-phenylenediamine study 1 (24h) / vehicle (DMSO) treated HepG2 cell sample
Relative Expression (log2-ratio):0.90104675Number of Samples:3 / 7
Experimental | 4-nitro-o-phenylenediamine study 1 (24h) |
HepG2 cells exposed to 2mM 4-nitro-o-phenylenediamine in DMSO solvent for 24 hours. ATC code:--- | |
Control | vehicle (DMSO) treated HepG2 cell sample |
HepG2 cells exposed to DMSO solvent for 24 hours. |
diclofenac study 7 (24h) / vehicle (PBS) treated HepG2 cell sample
Relative Expression (log2-ratio):0.8879967Number of Samples:3 / 3
Experimental | diclofenac study 7 (24h) |
HepG2 cells exposed to 100μM diclofenac in PBS solvent for 24 hours. ATC code:, , | |
Control | vehicle (PBS) treated HepG2 cell sample |
HepG2 cells exposed to 0.5% PBS solvent for 24 hours. |
glioma study 16 (LN-319) / normal astrocyte sample
Relative Expression (log2-ratio):0.86396074Number of Samples:2 / 3
Experimental | glioma study 16 (LN-319) |
Human glioma cell line LN319 was cultured in DMEM supplemented with 10% FCS (fetal calf serum) and antibiotics at 37°C and 5% CO2. | |
Control | normal astrocyte sample |
Normal brain astrocytes. Clonetics normal human astrocytes (NHA) from Cambrex (primary-derived cultures) and cultured according to the manufacturer's recommendations. |
brefeldin A study 1 (0.5ug/ml; HCT 116) / untreated HCT 116 cell sample
Relative Expression (log2-ratio):-0.86325455Number of Samples:3 / 3
Experimental | brefeldin A study 1 (0.5ug/ml; HCT 116) |
Human colon carcinoma cell line HCT116 was treated with 0.5 ug/ml brefeldin-A for 24 hours in McCOYs 5A medium supplemented with 10% heat inactivated FBS. ATC code:--- | |
Control | untreated HCT 116 cell sample |
Human colon carcinoma cell line HCT116 was grown in McCOYs 5A medium supplemented with 10% heat inactivated FBS. |